Balt
Created in 1977
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
1,132 17,301Activities
Technologies
Entity types
Location
10 Rue de la Croix Vigneron, 95160 Montmorency, France
Montmorency
France
Employees
Scale: 501-1000
Estimated: 413
Engaged corporates
3
3 1Added in Motherbase
1 year, 3 months ago
deeptech Value proposition
We are Balt.
Physician-inspired innovations. Patient-focused solutions.
For more than 45 years, Balt has been leading the way – collaborating with physicians and institutions to develop elegant neurovascular solutions. As the premier global neurovascular platform, always seeking to expand beyond boundaries, we are now bringing our innovation to the peripheral vascular space.
We introduced the first neurovascular intervention device in 1977. Now, we offer the world’s broadest portfolio of medical devices for ischemic and hemorrhagic stroke, as well as devices for peripheral embolization.
In 2015, we embarked on an ambitious journey and more than quintupled our revenue and workforce, and that was only the beginning. Now, the Balt family includes more than 700 talented team members at 13 sites in 11 countries around the world.
Be a part of our future: www.baltgroup.com
Interventionnal Neuroradiology, Research & Development, Innovation, and Medical DevicesOriginal language
BALT is a world leader in the design and manufacture of interventional neuroradiology devices to treat neurovascular pathologies (strokes, aneurysms, AVMs). By placing innovation at the center of its model, the company maintains its leading position in the neuroradiology field worldwide.
Since its creation in 1977 by Leopold Plowiecki, and at the instigation of Nicolas Plowiecki, his son, at the helm of the group from 2001 to 2018, BALT has been a leading player throughout the evolution of interventional radiology. Its unique model has enabled the company to always keep one step ahead and to provide cutting-edge therapeutic solutions and devices.
The success of BALT relies on the originality of several key assets:
• Strong and ongoing innovation to meet the expectations of the medical community: BALT’s many inventions are testimony to the company’s major influence on the progress of interventional neuroradiology. They include the flow-dependent microcatheter (MAGIC, 1987), as well as the intracranial braided stent (LEO in 2003 and LEO+ in 2007 and LEO+Baby in 2012), the stentriever (CATCH in 2005, CATCH+ in 2012 and CATCH VIEW in 2018) and the flow-diverter (SILK in 2006, SILK+ in 2012, and SILK VISTA BABY in 2018).
• Sustainable industry recognition and industrial partnerships to serve the healthcare community and patients.
• Multidisciplinary crossover talents: in its search for the highest performing neuroradiology products, BALT has always promoted a cross-innovation approach based on complementary expertise and disciplines. From chemistry to micromechanics, the production cycle is based on interdisciplinarity and constantly pursues end-product excellence.
As of December 2018, the company is headed by Pascal Girin.
Home - Balt Group : Balt Group
Inspiring Innovation
https://baltgroup.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 6 Jul 2023 | | |
 Intercommunalités de France NGO, Think Tank, Civic and Social Organizations | Intercommunalités de France NGO, Think Tank, Civic and Social Organizations | Other 31 Jan 2023 | | |
 Fondation Adolphe de Rothschild NGO, Think Tank, Hospitals and Health Care | Fondation Adolphe de Rothschild NGO, Think Tank, Hospitals and Health Care | Other 6 Apr 2023 | | |